| 3.14 0.5 (18.94%) | 07-26 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 3.67 |
1-year : | 4.29 |
| Resists | First : | 3.15 |
Second : | 3.67 |
| Pivot price | 2.33 |
|||
| Supports | First : | 2.34 |
Second : | 1.84 |
| MAs | MA(5) : | 2.76 |
MA(20) : | 2.29 |
| MA(100) : | 2.31 |
MA(250) : | 2.18 |
|
| MACD | MACD : | 0.1 |
Signal : | 0 |
| %K %D | K(14,3) : | 79.3 |
D(3) : | 77.5 |
| RSI | RSI(14): 75 |
|||
| 52-week | High : | 3.15 | Low : | 1.46 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ NXGL ] has closed above the upper band by 10.8%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 186.1% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 3 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 3.15 - 3.17 | 3.17 - 3.18 |
| Low: | 2.68 - 2.69 | 2.69 - 2.7 |
| Close: | 3.11 - 3.14 | 3.14 - 3.16 |
NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was founded in 1997 and is based in Langhorne, Pennsylvania.
Wed, 24 Jul 2024
NEXGEL (NASDAQ:NXGL) Stock Price Up 11.4% - Defense World
Tue, 23 Jul 2024
Loss-Making NEXGEL, Inc. (NASDAQ:NXGL) Expected To Breakeven In The Medium-Term - Simply Wall St
Thu, 27 Jun 2024
NEXGEL Subsidiary, CG Converting and Packaging, Announces it will Supply SilverSeal to Cintas Corporation - GlobeNewswire
Tue, 11 Jun 2024
NEXGEL and STADA Partner to Launch Leading European DAO Enzyme Supplement, Histasolv, in North America - GlobeNewswire
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Instruments & Supplies
|
|
| Shares Out | 6 (M) |
| Shares Float | 5 (M) |
| Held by Insiders | 22.8 (%) |
| Held by Institutions | 2.2 (%) |
| Shares Short | 18 (K) |
| Shares Short P.Month | 24 (K) |
| EPS | -0.57 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.81 |
| Profit Margin | -77.3 % |
| Operating Margin | -142.6 % |
| Return on Assets (ttm) | -21.4 % |
| Return on Equity (ttm) | -49.8 % |
| Qtrly Rev. Growth | 106.5 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0.65 |
| EBITDA (p.s.) | -0.53 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -3 (M) |
| Levered Free Cash Flow | -3 (M) |
| PE Ratio | -5.61 |
| PEG Ratio | 0 |
| Price to Book value | 3.82 |
| Price to Sales | 4.78 |
| Price to Cash Flow | -6.04 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|